The board approved a one-for-four reverse stock split to be effective on October 12, 2026. The action reduces outstanding Class A ordinary shares from approximately 35.7 million to roughly 8.9 million and adjusts convertible securities proportionally without requiring shareholder approval. NewGenIvf Group Limited operates in the fertility and reproductive health sector.
